The companies expanded their alliance to develop plasmid DNA drugs.

Takeda inaugurated expanded capacity of solid-dosage drugs at its site in Oranienburg, Germany.

The European Medicines Agency approved Prezista (darunavir) made via a continuous manufacturing process at Janssen's facility in Puerto Rico.

Sartorius Stedim Biotech expanded its range of single-use membrane chromatography solutions with Sartobind Cassettes.

A survey from The Pistoia Alliance found that just under a quarter (22%) of life-science companies are already using or experimenting with blockchain, but industry collaboration on security and storage standards is needed.

The patent was filed for a chewing gum composition with controlled release of cannabinoids and opioid agonists, and antagonists for addiction or dependence treatment.

The Own It Now channel allows buyers to view scheduled price decreases for used equipment and make purchases online.

In a new research conducted by SEA Vision and Zenith Technologies, 28% of respondents identified technology selection as the biggest challenge as the industry prepares to meet serialization deadlines.

The agency recommended approval of treatments for hepatitis C, cancer, multiple sclerosis, and arthritis.

The company successfully produced cell-based influenza vaccines at a commercial scale in its facility in NC.

The company announced that it has completed its 100th program using the pAVEway protein expression system, which was originally introduced to the market in 2007.

By purchasing the BMS Sword, Ireland facility, SK Biotek will be the first South Korean company to invest in pharmaceutical manufacturing in Ireland.

The annual meeting of the Honeywell Users Group for the Americas will discuss industrial automation.

FDA Commissioner Scott Gottlieb announced the agency will hold a public meeting on drug competition as part of its Drug Competition Action Plan.

Charlie Baker announced a plan to invest up to $500 million in the MA life-science industry.

The organization released principles related to workforce development, diversity, and inclusion that it believes are key to the biotechnology industry.

The European Commission approved Rixathon for use in all indications of its reference medicine, MabThera.

The company announced its new ISQ EC Single Quadrupole mass spectrometer and the new range of Thermo Scientific MAbPac RP 1-mm columns.

The company was granted patent rights to the use of CRISPR in a genomic integration method for eukaryotic cells.

The company added new products to its InfinityLab LC Series which will be showcased at HPLC 2017 in Prague.

The company has voluntarily recalled Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level because of a lack of sterility assurance.

The company is voluntarily recalling all unexpired lots of nitroglycerin products produced at its Houston location for potency issues.

The agency’s management board discussed plans for the relocation of EMA at its June 2017 meeting.

The company recalled a variety of products due to the potential of microbial contamination.

SK Biotek plans to operate the Swords, Ireland API manufacturing facility as a contract development and manufacturing site.

Basilea Pharmaceutica International Ltd. entered into a distribution and license agreement with Pfizer and Avir Pharma Inc. to distribute Basilea’s antifungal treatments.

The companies announced an agreement where Dorizoe will work with Baxter to develop more than 20 generic injectable products.

Selexis will be integrated with KBI Biopharma, which was acquired by JSR Life Sciences in 2015.